444
Views
6
CrossRef citations to date
0
Altmetric
Drug Profile

Ruxolitinib for the treatment of patients with polycythemia vera

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhiyong Cheng, Jianzhu Fu, Guimin Liu, Lijun Zhang, Qian Xu & Su-yun Wang. (2018) Angiogenesis in JAK2 V617F positive myeloproliferative neoplasms and ruxolitinib decrease VEGF, HIF-1 enesis in JAK2 V617F positive cells. Leukemia & Lymphoma 59:1, pages 196-203.
Read now

Articles from other publishers (5)

Alexandre Theocharides, Heinz Gisslinger, Valerio De Stefano, Vincenzo Accurso, Alessandra Iurlo, Timothy Devos, Miklos Egyed, Eric Lippert, Regina Garcia Delgado, Nathan Cantoni, Anders E. A. Dahm, Damianos Sotiropoulos, Erik Houtsma, Aoife Smyth, Amir Iqbal, Paola Di Matteo, Mike Zuurman & Peter A. W. te Boekhorst. (2023) Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study. European Journal of Haematology.
Crossref
Aishwarya Shinde, Kanan Panchal, Sumeet Katke, Rishi Paliwal & Akash Chaurasiya. (2022) Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives. Therapies 77:4, pages 425-443.
Crossref
Natasha Vinanica, Arthur Yong, Desmond Wong, Yi Tian Png, See Voon Seow, Masaru Imamura & Dario Campana. (2020) Specific stimulation of T lymphocytes with erythropoietin for adoptive immunotherapy. Blood 135:9, pages 668-679.
Crossref
Ma’mon M. Hatmal & Mutasem O. Taha. (2018) Combining Stochastic Deformation/Relaxation and Intermolecular Contacts Analysis for Extracting Pharmacophores from Ligand–Receptor Complexes. Journal of Chemical Information and Modeling 58:4, pages 879-893.
Crossref
Kate McKeage. (2015) Ruxolitinib: A Review in Polycythaemia Vera. Drugs 75:15, pages 1773-1781.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.